Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)

Overview

Study of the correlation between AGEsP and HbA1c and diabetic retinopathy prevalence: determination of cut-off value of AGEsP and HbA1c in type 2 diabetes diagnosis in China

Full Title of Study: “Determination of Cut-off Value of Advanced Glycation End-product and Glycosylated Haemoglobin in Type 2 Diabetes Diagnosis in China”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 2020

Detailed Description

To find the cut-off point of AGEsP and HbA1c for diagnosis of diabetes by drawing the logistic regression model between prevalence of retinopathy and AGEsP level and HbA1c level,and find the point where the prevalence of retinopathy changes most rapidly.

Interventions

  • Device: syringe, fundus camera etc
    • Physical examination, fundus examination, blood and urine samples collection

Clinical Trial Outcome Measures

Primary Measures

  • prevalence of retinopathy
    • Time Frame: 3 years
    • the prevalence of retinopathy in different AGEsP and HbA1c levels

Secondary Measures

  • incidence of retinopathy
    • Time Frame: 3 years
    • incidence of retinopathy in different AGEsP and HbA1c levels

Participating in This Clinical Trial

Inclusion Criteria

  • 20~70 years old; – Volunteer to participate in this study and signed informed consent. Exclusion Criteria:

-

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 70 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Zhongda Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Zilin Sun, director physician – Zhongda Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.